Fatty acid synthase expression in Paget's disease of the vulva

International Journal of Gynecological Pathology

Volumn 24, Issue 4, 2005, Pages 404-408

  Alo, Piero Luigi ^a   Galati, Gregorio M ^b   Sebastiani, Valeria ^a   Ricci, Francesca ^a   Visca, Paolo ^b   Mariani, Luciano ^b   Romagnoli, Francesca ^b   Lombardi, Giuseppe ^a   Di Tondo, Ugo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Fatty acid synthase; Paget; Vulva

Indexed keywords

FATTY ACID SYNTHASE; TUMOR MARKER;

ARTICLE; CANCER INVASION; CELL METABOLISM; CLINICAL ARTICLE; ENERGY METABOLISM; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PAGET SKIN DISEASE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; VULVA CANCER;

AGED; AGED, 80 AND OVER; CYTOPLASM; FATTY ACID SYNTHETASE COMPLEX; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; PAGET'S DISEASE, EXTRAMAMMARY; VULVAR NEOPLASMS;

EID: 25444452107     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pgp.0000170065.53813.81     Document Type: Article

References (39)

1. Curtin JP, Rubin SC, Jones WB, et al. Paget's disease of the vulva. Gynecol Oncol 1990;39:374-7.
2. Billings SD, Roth LM. Pseudoinvasive nodular extramammary Paget's disease of the vulva. Arch Pathol Lab Med 1998;122:471-4.
3. Wakil S. Fatty acid synthase: a proficient multifunctional enzyme. Biochemistry 1989;28:4523-30.
4. Latasa MJ, Moon YS, Kim KH, et al. Nutritional regulation of the fatty acid synthase promoter in vivo: sterol regulatory element binding protein functions through an upstream region containing a sterol regulatory element. Proc Natl Acad Sci USA 2000;97:10619-24.
5. Wilentz RE, Witters LA, Pizer ES. Lipogenic enzymes fatty acid synthase and acetyl-CoA carboxylase are co-expressed with sterol regulatory element binding protein and ki-67 in fetal tissues. Pediatr Dev Pathol 2000;3:525-31.
6. Alo PL, Visca P, Marci A, et al. Expression of fatty acid synthase as a predictor of recurrence in Stage I breast carcinoma patients. Cancer 1996;77:474-82.
7. Epstein JI, Carmichael M, Partin AW. OA-519 (fatty acid synthase) as an independent predictor of pathologic state in adenocarcinoma of the prostate. Urology 1995;45:81-6.
8. Nemoto T, Terashima S, Kogure M, et al. Overexpression of fatty acid synthase in oesophageal squamous cell dysplasia and carcinoma. Pathobiology 2001;69:297-303.
9. Wilkinson EJ, Brown H. Vulvar pagetoid urothelial intra-epithelial neoplasia (PUIN). Mod Pathol 2001;13:134A.
10. Wilkinson EJ, Brown HM. Vulvar Paget disease of urothelial origin. A report of three cases and a proposed classification of vulvar Paget disease. Hum Pathol 2002;33:549-54.
11. Fleming ID, Cooper JS, Henson DE, et al. AJCC Cancer Staging Handbook. 5th ed. Philadelphia, PA: Lippincott-Raven, 1998.
12. Weiss L, Hoffman GE, Schreiber R, et al. Fatty Acid biosynthesis in man: a pathway of minor importance. Purification, optimal assay conditions and organ distribution of fatty-acid synthase. Biol Chem Hoppe Seyler 1986;367:905-12.
13. Bresler R, Wakil SJ. Studies on the mechanism of fatty acid synthesis: the conversion of malonyl-CoA to long chain fatty acid. J Biol Chem 1961;236:1643-51.
14. Alo PL, Visca P, Mazzaferro S, et al. Immunohistochemical study of fatty acid synthase, ki67, proliferating cell nuclear antigen and p53 expression in hyperplastic parathyroids. Ann Diagn Pathol 1999;3:287-93.
15. Chalbos D, Escot C, Joyeux C, et al. Expression of the progestin-induced fatty acid synthetase in benign mastopathies and breast cancer as measured by RNA in situ hybridization. J Natl Cancer Inst 1990;82:602-6.
16. Oskovian B. Overexpression of fatty acid synthase in SKBR3 breast cancer cells line mediated via a transcriptional mechanism. Cancer Lett 2000;149:43-51.
17. Alo PL, Visca P, Framarino ML, et al. Immunohistochemical study of fatty acid synthase in ovarian neoplasms. Oncol Rep 2002;7:1383-8.
18. Swinnen JV, Vanderhoydonc F, Elgamal AA, et al. Selective activation of the fatty acid synthetic pathway in human prostate cancer. Int J Cancer 2000;18:176-9.
19. Visca P, Sebastiani V, Pizer ES, et al. Immunohistochemical expression and prognostic significance of fatty acid synthase and GLUT1 in bladder carcinoma. Anticancer Res 2003;23:335-9.
20. Camassei FD, Cozza R, Acquaviva A, et al. Expression of the lipogenic enzyme fatty acid synthase in retinoblastoma and its correlation with tumor aggressiveness. Invest Ophthalmol Vis Sci 2003;44:2399-403.
21. Gabrielson EW, Pinn ML, Testa JR, et al. Increased fatty acid synthase is a therapeutic target in mesothelioma. Clin Cancer Res 2001;7:153-7.
22. Innocenzi D, Alo PL, Balzani A, et al. Fatty acid synthase expression in melanoma. J Cutan Pathol 2003;30:23-8.
23. Takahiro T, Shinichi K, Toshimitsu S. Expression of fatty acid synthase as a prognostic indicator in s7oft tissue sarcomas. Clin Cancer Res 2003;9:2204-12.
24. Wang Y, Kuhajda FP, Li JN, et al. Fatty acid synthase expression in human breast cancer cell culture supernatants and in breast cancer patients. Cancer Lett 2001;167:99-104.
25. Rashid A, Pizer ES, Moga M, et al. Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am J Pathol 1997;150:201-8.
26. Pizer ES, Lax SF, Kuhajda FP, et al. Fatty acid synthase expression in endometrial carcinoma: correlation with cell proliferation and hormone receptors. Cancer 1998;83:528-37.
27. Sebastiani V, Visca P, Botti C, et al. Fatty acid synthase is a marker of increased risk of recurrence in endometrial carcinoma. Gynecol Oncol 2004;92:101-5.
28. Fox H, Wells M. Recent advances in the pathogenesis of the vulva. Histopathology 2003;42:209-16.
29. Wilkinson EJ. Premalignant and malignant tumors of the vulva. In: Kurman RJ, ed, Blaustein's Pathology of the Female Genital Tract. 5th ed. 2002.
30. Fine BA, Fowler LJ, Valente PT, et al. Minimally invasive Paget's disease of the vulva with extensive lymph node metastases. Gynecol Oncol 1995;57:262-5.
31. Scheistroen M, Trope C, Kaern J, et al. DNA ploidy and expression of p53 and C-erbB-2 in extramammary Paget's disease of the vulva. Gynecol Oncol 1997;64:88-92.
32. Crawford D, Nimmo M, Clement PB, et al. Prognostic factors in Paget's disease of the vulva: a study of 21 cases. Int J Gynecol Pathol 1999;18:73-83.
33. Ellis PE, Rolfe KJ, Crow JC, et al. The role of p53 and ki-67 in Paget's disease of the vulva and of the breast. Gynecol Oncol 2002;86:150-6.
34. Parker LP, Parker JR, Bodurka -Bevers D, et al. Paget's disease of the vulva: pathology, pattern of involvement and prognosis. Gynecol Oncol 2000;77:183-9.
35. Kuhajda FP, Jenner K, Wood FD, et al. Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proc Natl Acad Sci USA 1994;91:6379-83.
36. Vance D, Goldberg I, Mitsuhashi O, et al. Inhibition of fatty acid synthetases by the antibiotic cerulenin. Biochem Biophys Res Commun 1972;48:649-56.
37. Funabashi H, Kawaguchi A, Tomoda H, et al. Binding site cerulenin in fatty acid synthetase. J Biochem 1989;105:751-5.
38. Slade RF, Hunt DA, Pochet MM, et al. Characterization and inhibition of fatty acid synthase in pediatric tumor cell lines. Anticancer Res 2003;23:1235-43.
39. Pizer ES, Chrest FJ, Di Giuseppe JA, et al. Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines. Cancer Res 1988;58:4611-5.